Companies / Heron Therapeutics, Inc. /De/

Heron Therapeutics, Inc. /De/

Nasdaq: HRTXCIK 818033SAN DIEGO, CA

Financials

Revenue—
Net income$-20.20M
Total debt—
Cash$20.72M
Diluted EPS$-0.12
Shares outstanding189.9M

Ownership

189.9M shares outstanding · as of Aug 5, 2026
0.83%Insiders
Ownership
Insiders0.83%1,568,389
Institutions87.16%165,467,156
Public float12.02%22,816,762

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Collard Craig ACEOChief Executive Officer · Director
0.40%757,885
Forbes William PEVP, Chief Development Officer
0.12%221,611
Duarte IraEVP, Chief Financial Officer
0.10%195,356
Morgan AdamDirector
0.07%123,737
Christian WaageDirector
0.03%53,960
Cusack ThomasDirector
0.03%53,960
Dissanaike SharmilaDirector
0.03%53,960
Johnson Craig ADirector
0.03%53,960
Kaseta MichaelDirector
0.03%53,960
Hensley Mark EarlChief Operating Officer
——

Institutional holders 178

View all →
HolderValue% of shares
Rubric Capital Management LP$39.06M15.83%
Clearline Capital LP$15.91M6.44%
Adage Capital Partners Gp, L.L.C.$14.54M5.89%
Vanguard Group Inc$12.77M5.17%
Velan Capital Investment Management LP$11.38M4.61%
Orbimed Advisors LLC$7.85M5.17%
Tejara Capital Ltd$6.67M2.70%
Millennium Management LLC$6.11M4.02%
Tang Capital Management, LLC$5.00M3.29%
Palisade Capital Management, LP$4.91M3.23%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 30, 2026Cusack Thomas
Director
GrantCommon Stock$0+54K
53,960
0.03% of shares
low
Jan 30, 2026Morgan Adam
Director
GrantCommon Stock$0+54K
+77.33%
123,737
0.07% of shares
low
Jan 30, 2026Dissanaike Sharmila
Director
GrantCommon Stock$0+54K
53,960
0.03% of shares
low
Jan 30, 2026Kaseta Michael
Director
GrantCommon Stock$0+54K
53,960
0.03% of shares
low
Jan 30, 2026Christian Waage
Director
GrantCommon Stock$0+54K
53,960
0.03% of shares
low
Jan 30, 2026Johnson Craig A
Director
GrantCommon Stock$0+54K
53,960
0.03% of shares
low
Apr 30, 2026Collard Craig A
CEO
ExerciseRestricted Stock Units—-50K
-6.25%
750,316
0.40% of shares
low
Apr 30, 2026Collard Craig A
CEO
ExerciseRestricted Stock Units—-35K
-8.33%
382,675
0.20% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Vanguard Group IncPassive13G—9,820,384—
Clearline Capital LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
HRTX——427746102—